Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/90514
Full metadata record
DC FieldValueLanguage
dc.creatorMaia-Rocha, C
dc.creatorAdao, R
dc.creatorMendes-Ferreira, P
dc.creatorSantos-Ribeiro, D
dc.creatorRademaker, M
dc.creatorLeite-Moreira, A F
dc.creatorBrás-Silva C
dc.date.accessioned2022-09-15T20:45:26Z-
dc.date.available2022-09-15T20:45:26Z-
dc.date.issued2016
dc.identifier.issn0008-6363
dc.identifier.othersigarra:171601
dc.identifier.urihttps://hdl.handle.net/10216/90514-
dc.language.isoeng
dc.rightsrestrictedAccess
dc.subjectCiências da Saúde, Ciências médicas e da saúde
dc.subjectHealth sciences, Medical and Health sciences
dc.titleMolecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoFaculdade de Ciências da Nutrição e Alimentação
dc.subject.fosCiências médicas e da saúde
dc.subject.fosMedical and Health sciences
Appears in Collections:FCNAUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
171601.pdf
  Restricted Access
928.23 kBAdobe PDF    Request a copy from the Author(s)


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.